The conference brings together patent litigators, in-house counsel, judges, and policymakers to discuss key developments in UPC and national court litigation.The programme covers UPC case law and procedure, cross-border enforcement strategies, and sector-specific issues in pharma and biotech as well as technology and innovation, including topics such as SPCs, biosimilars, SEPs/FRAND, and complex multi-jurisdictional disputes, alongside extensive networking opportunities.

Speaking at this year’s summit:
Carl-Alexander Dinges, Partner - Tech & Innovation Patent Litigation Track
Daniel Hoppe, Partner - Pharma & Innovation Patent Litigation Track

Join us to explore the future of European patent litigation, from biosimilars to AI, FRAND, and the UPC.

View the interactive agenda
Download the summary brochure